Vitamin D Acts As Biological “Brake” For Low-Grade Prostate Cancer

Vitamin D Acts As Biological “Brake” For Low-Grade Prostate Cancer
shutterstock_170733779During the 249th National Meeting & Exposition of the American Chemical Society (ACS), the largest scientific society worldwide held in Denver, Colorado between 22nd and 26th of March, Dr. Bruce Hollis from the Medical University of South Carolina will present a clinical study entitled “Vitamin D in the prevention and treatment of cancer.” In this study, the research team shows that supplementation with vitamin D can have a significant impact on disease progression, with the ability to alter molecular and biochemical pathways, slowing or even decreasing the development of less aggressive, or low-grade, prostate tumors without undergoing surgery or radiation. During a prostate biopsy, upon tumor detection, pathologists use the Gleason Grading System to classify the tumor in terms of its aggressiveness. Tumors with Gleason scores of 7 and higher are considered aggressive and possibly metastatic, needing surgical removal of the prostate gland (prostatectomy) or radiation therapy. Prostate tumors with Gleason scores of 6 and lower are less aggressive and sometimes may not cause any symptoms or health issues during a patient's entire life. Dr. Hollis said in a news release that low-grade prostate tumors are not normally treated but put under
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *